αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma

Roberto Ria, Angelo Vacca, Domenico Ribatti, Francesco Di Raimondo, Francesca Merchionne, Franco Dammacco

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Background and Objectives. In multiple myeloma (MM), the mechanisms used by plasma cells to invade locally and metastasize are thought to be similar to those developed by solid tumors and include cell proliferation and secretion of extracellular matrix (ECM)-degrading enzymes following adhesion to ECM proteins. We studied these mechanisms in fresh bone marrow plasma cells of patients with MM after adhesion to the ECM proteins vitronectin (VN) and fibronectin (FN). Design and Methods. The ability of bone marrow plasma cells to adhere to VN and FN and the consequent formation of focal adhesion plaques on the cell surface, their composition and phosphorylation of several signal transduction proteins, cell proliferation and secretion of matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and urokinase-type plasminogen activator (uPA) were studied. Results. Plasma cells adhered to immobilized VN and FN. Adhesion was fully prevented by neutralizing antiαvβ3 integrin antibody. Integrin engagement caused aggregation of the plaques, which contained the β3 integrin subunit, some cytoskeletal proteins, tyrosine kinases, the Grb-2 adapter protein, and mitogen-activated protein (MAP) kinase. Free and immobilized VN and FN stimulated cell proliferation and the production and the release of uPA, and increased the release of the activated forms of MMP-2 and MMP-9 in an αvβ33 integrin-dependent manner. Interpretation and Conclusions. This ability of myeloma plasma cells to interact with VN and FN via αvβ3 integrin engagement suggests a novel mechanism for their invasion and spreading, since this interaction allows them to adhere to the substratum and enhances their proliferation and protease secretion.

Original languageEnglish
Pages (from-to)836-845
Number of pages10
JournalHaematologica
Volume87
Issue number8
Publication statusPublished - 2002

Fingerprint

Vitronectin
Multiple Myeloma
Fibronectins
Integrins
Plasma Cells
Focal Adhesions
Extracellular Matrix Proteins
Matrix Metalloproteinase 2
Urokinase-Type Plasminogen Activator
Cell Proliferation
Bone Marrow Cells
Focal Adhesion Kinase 1
Cytoskeletal Proteins
Matrix Metalloproteinase 9
Mitogen-Activated Protein Kinases
Matrix Metalloproteinases
Extracellular Matrix
Signal Transduction
Proteins
Peptide Hydrolases

Keywords

  • Extracellular matrix
  • Focal adhesion
  • Matrix metalloproteinases
  • Multiple myeloma
  • Urokinase-type plasminogen activator

ASJC Scopus subject areas

  • Hematology

Cite this

Ria, R., Vacca, A., Ribatti, D., Di Raimondo, F., Merchionne, F., & Dammacco, F. (2002). αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma. Haematologica, 87(8), 836-845.

αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma. / Ria, Roberto; Vacca, Angelo; Ribatti, Domenico; Di Raimondo, Francesco; Merchionne, Francesca; Dammacco, Franco.

In: Haematologica, Vol. 87, No. 8, 2002, p. 836-845.

Research output: Contribution to journalArticle

Ria, R, Vacca, A, Ribatti, D, Di Raimondo, F, Merchionne, F & Dammacco, F 2002, 'αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma', Haematologica, vol. 87, no. 8, pp. 836-845.
Ria R, Vacca A, Ribatti D, Di Raimondo F, Merchionne F, Dammacco F. αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma. Haematologica. 2002;87(8):836-845.
Ria, Roberto ; Vacca, Angelo ; Ribatti, Domenico ; Di Raimondo, Francesco ; Merchionne, Francesca ; Dammacco, Franco. / αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma. In: Haematologica. 2002 ; Vol. 87, No. 8. pp. 836-845.
@article{fe8c6becd85148dd990aaa9fb0b8c4df,
title = "αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma",
abstract = "Background and Objectives. In multiple myeloma (MM), the mechanisms used by plasma cells to invade locally and metastasize are thought to be similar to those developed by solid tumors and include cell proliferation and secretion of extracellular matrix (ECM)-degrading enzymes following adhesion to ECM proteins. We studied these mechanisms in fresh bone marrow plasma cells of patients with MM after adhesion to the ECM proteins vitronectin (VN) and fibronectin (FN). Design and Methods. The ability of bone marrow plasma cells to adhere to VN and FN and the consequent formation of focal adhesion plaques on the cell surface, their composition and phosphorylation of several signal transduction proteins, cell proliferation and secretion of matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and urokinase-type plasminogen activator (uPA) were studied. Results. Plasma cells adhered to immobilized VN and FN. Adhesion was fully prevented by neutralizing antiαvβ3 integrin antibody. Integrin engagement caused aggregation of the plaques, which contained the β3 integrin subunit, some cytoskeletal proteins, tyrosine kinases, the Grb-2 adapter protein, and mitogen-activated protein (MAP) kinase. Free and immobilized VN and FN stimulated cell proliferation and the production and the release of uPA, and increased the release of the activated forms of MMP-2 and MMP-9 in an αvβ33 integrin-dependent manner. Interpretation and Conclusions. This ability of myeloma plasma cells to interact with VN and FN via αvβ3 integrin engagement suggests a novel mechanism for their invasion and spreading, since this interaction allows them to adhere to the substratum and enhances their proliferation and protease secretion.",
keywords = "Extracellular matrix, Focal adhesion, Matrix metalloproteinases, Multiple myeloma, Urokinase-type plasminogen activator",
author = "Roberto Ria and Angelo Vacca and Domenico Ribatti and {Di Raimondo}, Francesco and Francesca Merchionne and Franco Dammacco",
year = "2002",
language = "English",
volume = "87",
pages = "836--845",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "8",

}

TY - JOUR

T1 - αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma

AU - Ria, Roberto

AU - Vacca, Angelo

AU - Ribatti, Domenico

AU - Di Raimondo, Francesco

AU - Merchionne, Francesca

AU - Dammacco, Franco

PY - 2002

Y1 - 2002

N2 - Background and Objectives. In multiple myeloma (MM), the mechanisms used by plasma cells to invade locally and metastasize are thought to be similar to those developed by solid tumors and include cell proliferation and secretion of extracellular matrix (ECM)-degrading enzymes following adhesion to ECM proteins. We studied these mechanisms in fresh bone marrow plasma cells of patients with MM after adhesion to the ECM proteins vitronectin (VN) and fibronectin (FN). Design and Methods. The ability of bone marrow plasma cells to adhere to VN and FN and the consequent formation of focal adhesion plaques on the cell surface, their composition and phosphorylation of several signal transduction proteins, cell proliferation and secretion of matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and urokinase-type plasminogen activator (uPA) were studied. Results. Plasma cells adhered to immobilized VN and FN. Adhesion was fully prevented by neutralizing antiαvβ3 integrin antibody. Integrin engagement caused aggregation of the plaques, which contained the β3 integrin subunit, some cytoskeletal proteins, tyrosine kinases, the Grb-2 adapter protein, and mitogen-activated protein (MAP) kinase. Free and immobilized VN and FN stimulated cell proliferation and the production and the release of uPA, and increased the release of the activated forms of MMP-2 and MMP-9 in an αvβ33 integrin-dependent manner. Interpretation and Conclusions. This ability of myeloma plasma cells to interact with VN and FN via αvβ3 integrin engagement suggests a novel mechanism for their invasion and spreading, since this interaction allows them to adhere to the substratum and enhances their proliferation and protease secretion.

AB - Background and Objectives. In multiple myeloma (MM), the mechanisms used by plasma cells to invade locally and metastasize are thought to be similar to those developed by solid tumors and include cell proliferation and secretion of extracellular matrix (ECM)-degrading enzymes following adhesion to ECM proteins. We studied these mechanisms in fresh bone marrow plasma cells of patients with MM after adhesion to the ECM proteins vitronectin (VN) and fibronectin (FN). Design and Methods. The ability of bone marrow plasma cells to adhere to VN and FN and the consequent formation of focal adhesion plaques on the cell surface, their composition and phosphorylation of several signal transduction proteins, cell proliferation and secretion of matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and urokinase-type plasminogen activator (uPA) were studied. Results. Plasma cells adhered to immobilized VN and FN. Adhesion was fully prevented by neutralizing antiαvβ3 integrin antibody. Integrin engagement caused aggregation of the plaques, which contained the β3 integrin subunit, some cytoskeletal proteins, tyrosine kinases, the Grb-2 adapter protein, and mitogen-activated protein (MAP) kinase. Free and immobilized VN and FN stimulated cell proliferation and the production and the release of uPA, and increased the release of the activated forms of MMP-2 and MMP-9 in an αvβ33 integrin-dependent manner. Interpretation and Conclusions. This ability of myeloma plasma cells to interact with VN and FN via αvβ3 integrin engagement suggests a novel mechanism for their invasion and spreading, since this interaction allows them to adhere to the substratum and enhances their proliferation and protease secretion.

KW - Extracellular matrix

KW - Focal adhesion

KW - Matrix metalloproteinases

KW - Multiple myeloma

KW - Urokinase-type plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=0035986760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035986760&partnerID=8YFLogxK

M3 - Article

C2 - 12161360

AN - SCOPUS:0035986760

VL - 87

SP - 836

EP - 845

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 8

ER -